Maintenance therapy in acute myeloid leukemia: an evidence-based review of randomized trials

被引：45
作者：
Rashidi, Armin [1 ]
Walter, Roland B. [2 ,3 ,4 ]
Tallman, Martin S. [5 ]
Appelbaum, Frederick R. [2 ,6 ]
DiPersio, John F. [1 ]
机构：
[1] Washington Univ, Sch Med, Dept Med,Div Oncol, Sect Bone Marrow Transplantat & Leukemia Program, St Louis, MO 63110 USA
[2] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA
[3] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA
[4] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Med, Weill Cornell Med Coll, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA
[6] Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98195 USA
来源：
BLOOD | 2016年 / 128卷 / 06期
基金：
美国国家卫生研究院;
关键词：
ACUTE MYELOGENOUS LEUKEMIA; QUALITY-OF-LIFE; STEM-CELL TRANSPLANTATION; SOUTHWEST-ONCOLOGY-GROUP; HIGH-DOSE CYTARABINE; INTENSIVE CHEMOTHERAPY; RECOMBINANT INTERLEUKIN-2; POSTREMISSION THERAPY; ALLOGENEIC HSCT; INTENSIFICATION THERAPY;
D O I：
10.1182/blood-2016-03-674127
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：763 / 773
页数：11
相关论文
共 50 条
[41]   Post-remission therapy for acute myeloid leukemia [J].
Schlenk, Richard F. .
HAEMATOLOGICA, 2014, 99 (11) :1663-1670
[42]   Risk-adapted therapy in acute myeloid leukemia [J].
Fiegl, M. ;
Hiddemann, W. .
INTERNIST, 2012, 53 (04) :392-+
[43]   Therapy-Related Myelodysplasia and Acute Myeloid Leukemia [J].
Bhatia, Smita .
SEMINARS IN ONCOLOGY, 2013, 40 (06) :666-675
[44]   Postremission therapy for acute myeloid leukemia in the first remission [J].
Kim, Seung Tai ;
Jung, Chul Won ;
Lee, Jeeyun ;
Kwon, Jung Mi ;
Oh, Sung Young ;
Park, Byeong-Bae ;
Lee, Hyo Rak ;
Kim, Hyun Jung ;
Kim, Kihyun ;
Kim, Won Seog ;
Ahn, Jin Seok ;
Kang, Won Ki ;
Park, Keunchil .
LEUKEMIA & LYMPHOMA, 2007, 48 (05) :937-943
[45]   VALUE OF MAINTENANCE THERAPY WITH CHEMOTHERAPY OR INTERFERON DURING REMISSION OF ACUTE MYELOID-LEUKEMIA [J].
PALVA, IP ;
ALMQVIST, A ;
ELONEN, E ;
HANNINEN, A ;
JOUPPILA, J ;
JARVENTIE, G ;
KOIVUNEN, E ;
KATKA, K ;
LAHTINEN, R ;
OIVANEN, T ;
PELLINIEMI, TT ;
RAJAMAKI, A ;
REMES, K ;
RUUTU, T ;
TIMONEN, T ;
WASASTJERNA, C ;
VILPO, J ;
VOLIN, L ;
VUOPIO, P .
EUROPEAN JOURNAL OF HAEMATOLOGY, 1991, 47 (03) :229-233
[46]   Maintenance therapies in acute myeloid leukemia: the renaissance of an old therapeutic concept [J].
Bewersdorf, Jan Philipp ;
Tallman, Martin S. ;
Stahl, Maximilian .
CURRENT OPINION IN ONCOLOGY, 2021, 33 (06) :658-669
[47]   FLT3 Inhibition as Therapy in Acute Myeloid Leukemia: A Record of Trials and Tribulations [J].
Fathi, Amir T. ;
Chabner, Bruce A. .
ONCOLOGIST, 2011, 16 (08) :1162-1174
[48]   Core-binding factor acute myeloid leukemia: Heterogeneity, monitoring, and therapy [J].
Solh, Melhem ;
Yohe, Sophia ;
Weisdorf, Daniel ;
Ustun, Celalettin .
AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (12) :1121-1131
[49]   Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Pediatric Acute Lymphoblastic Leukemia: Update of the 2005 Evidence-Based Review [J].
Oliansky, Denise M. ;
Camitta, Bruce ;
Gaynon, Paul ;
Nieder, Michael L. ;
Parsons, Susan K. ;
Pulsipher, Michael A. ;
Dillon, Hildy ;
Ratko, Thomas A. ;
Wall, Donna ;
McCarthy, Philip L., Jr. ;
Hahn, Theresa .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (04) :505-522
[50]   Acute Myeloid Leukemia: A Concise Review [J].
Saultz, Jennifer N. ;
Garzon, Ramiro .
JOURNAL OF CLINICAL MEDICINE, 2016, 5 (03)
12345